Advertisement

Topics

GeneCentric Therapeutics Appoints Michael V. Milburn, PhD, Chief Scientific Officer

10:00 EDT 10 Sep 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
GeneCentric Therapeutics, Inc. today announced the appointment of Michael V. Milburn, PhD, as Chief Scientific Officer (CSO). Dr. Milburn, who joins GeneCentric from Metabolon, Inc. where he was CSO, has more than 25 years of R&...

Other Sources for this Article

GeneCentric Therapeutics, Inc.
Walter M. Capone, 984-329-3837
Chief Business Officer
walter.capone@GeneCentric.com

NEXT ARTICLE

More From BioPortfolio on "GeneCentric Therapeutics Appoints Michael V. Milburn, PhD, Chief Scientific Officer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...